Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-004942

CVP, Chief Financial Officer sold 11,250 shares at $74.40 ($837,035)

  • CVP, Chief Financial Officer acquired 11,250 shares (option exercise)
  • CVP, Chief Financial Officer gave up 1,406 shares (to pay taxes)
  • CVP, Chief Financial Officer acquired 13,400 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-07 Shares withheld for taxes : show line 1 in the form 10b5-1 −1,406 $74.92 $105,338 27,698 D
2025-05-08 Grant or award : show line 2 in the form 10b5-1 +13,400 41,098 D
2025-05-09 Exercise or conversion : show line 3 in the form 10b5-1 +11,250 $45.28 $509,363 52,348 D
2025-05-09 Sale : show line 4 in the form 10b5-1 −11,250 $74.40 $837,035 41,098 D
Open-market sales · 11,250 sh · avg $74.40 · $837,035

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-05-08 Grant or award : show line 5 in the form 10b5-1 Employee Stock Option (Right to Acquire) +75,200 75,200 D
2025-05-08 Grant or award : show line 6 in the form 10b5-1 Performance Rights +13,400 13,400 D
2025-05-09 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) −11,250 0 D
Loading xslF345X05/doc4.xml…